Elevated Serum Syndecan-1 Levels Are Associated with Obesity-Related Complications in Children

AuthorMeltem Erolen
AuthorAslıhan Tenekecigilen
AuthorAbdulrahman Ozelen
AuthorOzlem Bostan Gayreten
AuthorOkan Yuceen
AuthorCanan Yılmazen
OrcidMeltem Erol [0000-0002-7672-1854]en
OrcidAslıhan Tenekecigil [0000-0002-3893-7136]en
OrcidAbdulrahman Ozel [0000-0001-8947-420X]en
OrcidOzlem Bostan Gayret [0000-0003-4121-8009]en
OrcidOkan Yuce [0000-0001-6043-1062]en
OrcidCanan Yılmaz [0000-0002-6799-6522]en
Issued Date2025-02-28en
AbstractBackground: Syndecan-1 plays a crucial role in cell differentiation, growth, adhesion, wound healing, and inflammatory processes. It has been linked to obesity, particularly overweight and chronic low-grade inflammation. Objectives: This study aimed to compare serum syndecan-1 levels between obese children and a healthy control group and to investigate the relationship between serum syndecan-1 levels and renal and cardiovascular complications associated with obesity in children. Methods: We assessed 30 obese and 30 healthy children aged 8 - 16 years. Blood samples were collected from both groups to measure serum aspartate aminotransferase (AST), syndecan-1, fasting blood glucose (FBG), alanine aminotransferase (ALT), creatinine, and urea concentrations. In the obese group, high-density lipoprotein cholesterol (HDL-C), insulin, triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels were also measured, along with homeostasis model assessment of insulin resistance (HOMA-IR). Results: The mean serum syndecan-1 levels in the obese and control groups were 15.65 ± 10.01 ng/mL and 6.99 ± 3.79 ng/mL, respectively, with a significantly higher level observed in the obese group (P < 0.005). Significant differences were also found in BMI, BMI SDS, creatinine, AST, and ALT levels between the two groups (P < 0.05), with all parameters being higher in the obese group. A significant positive linear association was identified between syndecan-1 levels and creatinine, TG, and BMI SDS (r = 0.711, r = 0.630, r = 0.682, P < 0.01). Additionally, a strong negative correlation was found between syndecan-1 and HDL-C levels (r = -0.609, P < 0.001). No significant linear relationship was detected between syndecan-1 levels and LDL-C, ALT, AST, glucose, urea, insulin levels, or HOMA-IR measurements (P > 0.05). Linear regression analysis revealed that serum creatinine levels and BMI SDS were significantly linked to changes in syndecan-1 levels. Conclusions: Syndecan-1 is elevated in obese children due to inflammation and may serve as an early biomarker for endothelial damage. It can be useful in detecting obesity-related renal damage and cardiovascular risk in children.en
DOIhttps://doi.org/10.5812/ijp-148999en
KeywordSyndecan 1en
KeywordObesityen
KeywordChildrenen
PublisherBrieflandsen
TitleElevated Serum Syndecan-1 Levels Are Associated with Obesity-Related Complications in Childrenen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijp-In_Press-In_Press-148999-publish-pdf.pdf
Size:
387.94 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF